Randomized Clinical Trial on Reduction of Radiotherapy Dose to the Elective Neck in Head and Neck Squamous Cell Carcinoma: Results on the Quality of Life

被引:6
|
作者
Deschuymer, S. [1 ]
Nevens, D. [1 ,5 ]
Duprez, F. [2 ]
Daisne, J. F. [1 ,3 ]
Voordeckers, M. [4 ]
De Neve, W. [2 ]
Nuyts, S. [1 ]
机构
[1] KU Leuven Univ Leuven, Dept Radiat Oncol, Univ Hosp Leuven, Herestr 49, B-3000 Leuven, Belgium
[2] Ghent Univ Hosp, Dept Radiotherapy Oncol, Ghent, Belgium
[3] Catholic Univ Louvain, Dept Radiat Oncol, CHU UCL Namur, Site Ste Elisabeth, Namur, Belgium
[4] Vrije Univ Brussel, Dept Radiat Oncol, UZ Brussel, Brussels, Belgium
[5] Univ Antwerp, Dept Radiat Oncol, Iridium Kanker Netwerk, Fac Med & Hlth Sci, Antwerp, Belgium
关键词
Quality of life; Head and neck cancer; Radiotherapy; Elective nodes; Dose reduction; INTENSITY-MODULATED RADIOTHERAPY; CANCER PATIENTS; ACCELERATED RADIOTHERAPY; EUROPEAN-ORGANIZATION; EORTC QLQ-H-AND-N35; RADIATION-THERAPY; LATE TOXICITY; QUESTIONNAIRE; CHEMOTHERAPY; COMBINATION;
D O I
10.1007/s11136-020-02628-w
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose A randomized trial was initiated to investigate whether a reduction of the dose to the elective nodal sites would result in less toxicity and improvement in Quality of Life (QoL) without compromising tumor control. This paper aimed to compare QoL in both treatment arms. Methods Two-hundred head and neck cancer patients treated with radiotherapy (RT) or chemo-RT were randomized (all stages, mean age: 60 years, M/F: 82%/18%). The elective nodal volumes of patients randomized in the experimental arm were treated up to a 40 Gy equivalent dose. In the standard arm, the elective nodal volumes were treated up to a 50 Gy equivalent dose. The QoL data were collected using The European Organization for Research and Treatment of Cancer (EORTC) core questionnaire QLQ-C30 and the EORTC Head and Neck Cancer module (H&N35). Results A trend toward less decline in QoL during treatment was observed in the 40 Gy arm compared to the 50 Gy arm. Statistically significant differences for global health status, physical functioning, emotional functioning, speech problems, and trouble with social eating in favor of the 40 Gy arm were observed. A clinically relevant better outcome in the 40 Gy arm was found for physical functioning at the end of therapy. Conclusion QoL during RT for head and neck cancer tends to be less impaired in the 40 Gy arm. However, reducing the dose only on the elective neck does not result in clinically relevant improvement of QoL. Therefore, additional treatment strategies must be examined to further improve the QoL of HNSCC patients.
引用
收藏
页码:117 / 127
页数:11
相关论文
共 50 条
  • [21] Head and neck squamous cell carcinoma of unknown primary: Neck dissection and radiotherapy or definitive radiotherapy
    Demiroz, Candan
    Vainshtein, Jeffrey M.
    Koukourakis, Georgios V.
    Gutfeld, Orit
    Prince, Mark E.
    Bradford, Carol R.
    Wolf, Gregory T.
    McLean, Scott
    Worden, Francis P.
    Chepeha, Douglas B.
    Schipper, Matthew J.
    McHugh, Jonathan B.
    Eisbruch, Avraham
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (11): : 1589 - 1595
  • [22] Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma A Randomized Clinical Trial
    Siu, Lillian L.
    Waldron, John N.
    Chen, Bingshu E.
    Winquist, Eric
    Wright, Jim R.
    Nabid, Abdenour
    Hay, John H.
    Ringash, Jolie
    Liu, Geoffrey
    Johnson, Ana
    Shenouda, George
    Chasen, Martin
    Pearce, Andrew
    Butler, James B.
    Breen, Stephen
    Chen, Eric Xueyu
    FitzGerald, T. J.
    Childs, T. J.
    Montenegro, Alexander
    O'Sullivan, Brian
    Parulekar, Wendy R.
    JAMA ONCOLOGY, 2017, 3 (02) : 220 - 226
  • [23] RADIOSENSITIZER IN ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA - RESULTS OF A RANDOMIZED TRIAL - INSTITUTE CURIE
    BRUNIN, S
    BATAINI, JP
    ASSELAIN, B
    JAULLERY, C
    GHOSSEIN, NA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (09): : 1227 - 1227
  • [24] Elective Neck Dissection During Salvage Surgery for Locally Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy With Elective Nodal Irradiation
    Dagan, Roi
    Morris, Christopher G.
    Kirwan, Jessica M.
    Werning, John W.
    Vaysberg, Mikhail
    Amdur, Robert J.
    Mendenhall, William M.
    LARYNGOSCOPE, 2010, 120 (05): : 945 - 952
  • [25] Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
    Maguire, Patrick D.
    Neal, Charles R.
    Hardy, Stuart M.
    Schreiber, Andrew M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1210 - 1216
  • [26] Altered fractionation radiotherapy in head and neck squamous cell carcinoma
    Mallick, Supriya
    Benson, Rony
    Julka, Pramod K.
    Rath, Goura K.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2016, 28 (02) : 73 - 80
  • [27] RADIOTHERAPY FOR BASALOID SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    LARNER, JM
    MALCOLM, RH
    MILLS, SE
    FRIERSON, HF
    BANKS, ER
    LEVINE, PA
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1993, 15 (03): : 249 - 252
  • [28] Alternating chemo-radiotherapy versus partly accelerated radiotherapy in advanced squamous cell carcinoma of the head and neck: Results of phase III randomized trial
    Corvo, R
    Benasso, M
    Sanguineti, G
    Lionetto, R
    Numico, G
    Bacigalupo, A
    Ricci, I
    Margarino, G
    Grimaldi, A
    Chiarlone, R
    Merlano, M
    Vitale, V
    Rosso, R
    ANNALS OF ONCOLOGY, 2000, 11 : 3 - 3
  • [29] Radiotherapy and Survival for Head and Neck Squamous Cell Carcinoma: Results from the SEER Database
    Shirazi, Haider
    Choo, Julia
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (06): : 607 - 607
  • [30] Evaluation of Quality of Life and Organ Function in Head and Neck Squamous Cell Carcinoma
    Martino, Rosemary
    Ringash, Jolie
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2008, 22 (06) : 1239 - +